1 | SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer. (Botta GP, Kato S, Patel H, Fanta P, Lee S, Okamura R, Kurzrock R) JCI Insight 2021 Sep 22;6(18) 29 Citations |
1 | Authors' Reply: SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. (Fonkem E, Peng S, Berens M, Mukherjee S) J Neuropathol Exp Neurol 2021 Feb 22;80(3):290-291 1 Citation |
1 | SMARCB1 Gene Mutation Predisposes to Earlier Development of Glioblastoma: A Case Report of Familial GBM. (Mukherjee S, Stroberg E, Wang F, Morales L, Shan Y, Rao A, Huang JH, Wu E, Fonkem E) J Neuropathol Exp Neurol 2020 May 01;79(5):562-565 5 Citations |
1 | Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression. (Pottier N, Cheok MH, Yang W, Assem M, Tracey L, Obenauer JC, Panetta JC, Relling MV, Evans WE) Hum Mol Genet 2007 Oct 01;16(19):2261-71 40 Citations |